Efficacy and Safety of ABP-450 (PrabotulinumtoxinA) in Adults With Cervical Dystonia: Results From the Open-label Extension of a Phase 2 Trial

被引：0
|
作者：
Jankovic, Joseph [1 ]
Oh, Chad [2 ]
Liu, Yan [2 ]
Abdul-Musawir, Najeebah [2 ]
Comella, Cynthia [3 ]
机构：
[1] Baylor Coll Med, St Lukes Med Ctr, Dept Neurol, Parkinsons Dis Ctr & Movement Disorders Clin, McNair Campus,7200 Cambridge St,Suite 9A, Houston, TX USA
[2] AEON Biopharma Inc, Irvine, CA USA
[3] Rush Univ, Med Ctr, Chicago, IL USA
来源：
TOXICON | 2024年 / 237卷
关键词：
Cervical dystonia; Type A botulinum toxins; PrabotulinumtoxinA; Torticollis; Dyskinesias; Neurologic manifestations;
D O I：
10.1016/j.toxicon.2024.107415
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：36 / 37
页数：3
相关论文
共 50 条
  • [41] Adalimumab for nail psoriasis: Efficacy and safety from the open-label extension of a phase-3, randomized, placebo-controlled trial
    Gottlieb, Alice B.
    Elewski, Boni E.
    Okun, Martin M.
    Bagel, Jerry
    Poulin, Yves
    Gu, Yihua
    Williams, David A.
    Valdecantos, Wendell C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB33 - AB33
  • [42] Efficacy and Safety of Switching from Adalimumab to Sarilumab in an Open-label Extension of a Phase 3 Monotherapy Trial in Patients with Active Rheumatoid Arthritis
    Burmester, Gerd
    Fiore, Stefano
    Hu, Chih-Chi
    Fay, Jonathan
    Lee, Eun-Bong
    Genovese, Mark
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1035 - 1035
  • [43] Efficacy and Safety of Switching from Adalimumab to Sarilumab in an Open-Label Extension of a Phase 3 Monotherapy Trial in Patients with Active Rheumatoid Arthritis
    Burmester, Gerd R.
    Fiore, Stefano
    Hu, Chih-Chi
    Fay, Jonathan
    Lee, Eun Bong
    Genovese, Mark C.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [44] DURABILITY OF EFFICACY AND SAFETY OF ROFLUMILAST CREAM 0.3% IN ADULTS WITH CHRONIC PLAQUE PSORIASIS FROM A 52-WEEK, PHASE 2 OPEN-LABEL SAFETY TRIAL
    Lebwohl, M.
    Gold, Stein L.
    M, Gooderham
    Papp, K. A.
    Ferris, L. K.
    Adam, D. N.
    Hong, H. C. H.
    Kircik, L. H.
    Zirwas, M.
    Burnett, P.
    Higham, R.
    Krupa, D.
    Berk, D. R.
    VALUE IN HEALTH, 2023, 26 (06) : S22 - S23
  • [45] Safety and Efficacy of Natalizumab in Japanese Patients with Relapsing-Remitting Multiple Sclerosis: Open-Label Extension Study of a Phase 2 Trial
    Saida T.
    Kira J.-I.
    Kishida S.
    Yamamura T.
    Ohtsuka N.
    Ling Y.
    Torii S.
    Lucas N.
    Kuesters G.
    Steiner D.
    Tibung J.T.
    Neurology and Therapy, 2017, 6 (1) : 39 - 55
  • [46] Single-Dose Pharmacokinetics and Safety of Atogepant in Adults With Hepatic Impairment: Results From an Open-Label, Phase 1 Trial
    Boinpally, Ramesh
    Jakate, Abhijeet
    Butler, Matthew
    Borbridge, Lisa
    Periclou, Antonia
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (07): : 726 - 733
  • [47] Single-Dose Pharmacokinetics and Safety of Ubrogepant in Adults With Hepatic Impairment: Results From an Open-Label, Phase 1 Trial
    Boinpally, Ramesh
    Lu, Kaifeng
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (07): : 857 - 864
  • [48] Bimekizumab Safety and Efficacy in Patients with Psoriatic Arthritis: 3-Year Results from a Phase 2b Open-Label Extension Study
    Coates, L. C.
    Warren, R. B.
    Ritchlin, C. T.
    Gossec, L.
    Merola, J. F.
    Assudani, D.
    Coarse, J.
    Eells, J.
    Ink, B.
    McInnes, I. B.
    SWISS MEDICAL WEEKLY, 2021, 151 : S20 - S20
  • [49] Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study
    Ferrante, Marc
    Feagan, Brian G.
    Panes, Julian
    Baert, Filip
    Louis, Edouard
    Dewit, Olivier
    Kaser, Arthur
    Duan, W. Rachel
    Pang, Yinuo
    Lee, Wan-Ju
    Gustafson, Dawn
    Liao, Xiaomei
    Wallace, Kori
    Kalabic, Jasmina
    D'Haens, Geert R.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (12): : 2001 - 2010
  • [50] BIMEKIZUMAB SAFETY AND EFFICACY IN PATIENTS WITH PSORIATIC ARTHRITIS: 3-YEAR RESULTS FROM A PHASE 2B OPEN-LABEL EXTENSION STUDY
    Coates, L. C.
    Warren, R. B.
    Ritchlin, C. T.
    Gossec, L.
    Merola, J. F.
    Assudani, D.
    Coarse, J.
    Eells, J.
    Ink, B.
    Mcinnes, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 779 - 780
12345